Paloma Partners Management Co Makes New $1.33 Million Investment in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Paloma Partners Management Co purchased a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 14,114 shares of the company's stock, valued at approximately $1,325,000.

Several other institutional investors also recently modified their holdings of GEHC. Mesirow Financial Investment Management Inc. lifted its holdings in GE HealthCare Technologies by 39.6% during the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 4,084 shares of the company's stock worth $383,000 after buying an additional 1,159 shares during the period. LMR Partners LLP acquired a new position in shares of GE HealthCare Technologies in the third quarter worth approximately $7,387,000. B. Metzler seel. Sohn & Co. Holding AG bought a new stake in GE HealthCare Technologies in the third quarter valued at approximately $1,396,000. Bank of Montreal Can increased its position in GE HealthCare Technologies by 27.5% during the 2nd quarter. Bank of Montreal Can now owns 696,446 shares of the company's stock valued at $54,964,000 after purchasing an additional 150,137 shares during the period. Finally, Douglas Lane & Associates LLC raised its holdings in GE HealthCare Technologies by 2.2% during the 3rd quarter. Douglas Lane & Associates LLC now owns 460,004 shares of the company's stock worth $43,171,000 after purchasing an additional 10,099 shares during the last quarter. Institutional investors own 82.06% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on GEHC shares. Evercore ISI upped their price objective on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the company an "outperform" rating in a research note on Tuesday, October 1st. Stifel Nicolaus upped their price target on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a "buy" rating in a research report on Monday, September 30th. Wells Fargo & Company increased their price target on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an "overweight" rating in a report on Thursday, October 31st. BTIG Research raised GE HealthCare Technologies from a "neutral" rating to a "buy" rating and set a $100.00 price objective on the stock in a research note on Wednesday, September 18th. Finally, UBS Group cut GE HealthCare Technologies from a "neutral" rating to a "sell" rating and decreased their target price for the stock from $84.00 to $74.00 in a research note on Thursday, September 26th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $95.46.

GE HealthCare Technologies Stock Down 0.6 %

NASDAQ GEHC traded down $0.51 during mid-day trading on Tuesday, hitting $82.57. The company's stock had a trading volume of 2,026,619 shares, compared to its average volume of 3,063,322. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The company's 50 day simple moving average is $87.62 and its 200 day simple moving average is $83.67. GE HealthCare Technologies Inc. has a twelve month low of $67.00 and a twelve month high of $94.55. The firm has a market capitalization of $37.72 billion, a price-to-earnings ratio of 22.68, a PEG ratio of 2.97 and a beta of 1.07.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, topping the consensus estimate of $1.06 by $0.08. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The company had revenue of $4.86 billion during the quarter, compared to the consensus estimate of $4.87 billion. During the same period in the previous year, the firm posted $0.99 earnings per share. The firm's revenue for the quarter was up .9% on a year-over-year basis. Analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.17%. The ex-dividend date is Tuesday, January 14th. This is a positive change from GE HealthCare Technologies's previous quarterly dividend of $0.03. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 3.30%.

Insider Activity at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the sale, the chief executive officer now owns 24,298 shares in the company, valued at approximately $2,101,291.04. This trade represents a 12.83 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.27% of the stock is owned by insiders.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.